Janux stock plunges after hours following mCRPC trial data
Investing.com - RBC Capital has raised its price target on The Ensign Group Inc. (NASDAQ:ENSG) to $206.00 from $177.00 while maintaining an Outperform rating on the stock. The new target represents potential upside from the current price of $177.30, with analyst targets ranging from $177 to $220, according to InvestingPro data.
The price target increase follows The Ensign Group’s third-quarter results, which RBC described as showing "record growth" and "strong occupancy." The healthcare company also raised its guidance for 2025. This aligns with the company’s impressive 17.55% revenue growth over the last twelve months.
RBC noted that The Ensign Group delivered strong performance in the third quarter, with adjusted EBITDAR coming in 3.0% above consensus expectations. The company reported both a beat on quarterly results and raised future guidance. InvestingPro data shows four analysts have revised their earnings upwards for the upcoming period, with EPS forecast for FY2025 at $6.66.
The analyst highlighted consistent operational momentum at The Ensign Group, supported by improvements in same-store and transitioning facility metrics, along with strong acquisition growth.
The price target adjustment represents a $29 increase from RBC’s previous valuation of The Ensign Group shares.
In other recent news, Ensign Group Inc. reported its third-quarter 2025 earnings, surpassing analyst expectations. The company achieved an adjusted earnings per share (EPS) of $1.64, exceeding the forecasted $1.61. Ensign Group’s revenue also surpassed predictions, reaching $1.3 billion compared to the anticipated $1.28 billion. These figures indicate a robust financial performance for the quarter. Although the stock price movement is not discussed here, the earnings results themselves highlight the company’s strong market position. This development is part of recent news concerning Ensign Group’s performance. Investors and analysts are likely to take note of these positive earnings and revenue results. The company’s ability to exceed expectations could influence future analyst assessments and investor decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.